Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial-Reference-Cited by-同舟云学术

Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial

Published:2008-02 Issue:2 Volume:30 Page:249-259
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Serebruany Victor L.,Malinin Alex I.,Pokov Alex N.,Hanley Daniel F.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

2. Update on aspirin in treatment and prevention of cardiovascular disease;Hennekens;Am J Manag Care,2002

3. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke;Diener;J Neurol Sci,1996

4. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial [published correction appears in Lancet. 2007;369:274];Halkes;Lancet,2006

5. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE);Lancet,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke;Journal of the Neurological Sciences;2022-10

2. Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis;Annals of Translational Medicine;2022-03

3. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis;Journal of Neurology;2020-06-09

4. Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?;Frontiers in Pharmacology;2019-11-08

5. Microparticles and cardiovascular diseases;Annals of Medicine;2019-05-19